Ilan Y - Search Results

1

Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects.

Ilan Y. Ilan Y. Mol Ther Methods Clin Dev. 2020 Jun 10;18:335-344. doi: 10.1016/j.omtm.2020.06.006. eCollection 2020 Sep 11. Mol Ther Methods Clin Dev. 2020. PMID: 32671136 Free PMC article. Review.

2

Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies.

Khoury T, Ilan Y. Khoury T, et al. Among authors: ilan y. Front Immunol. 2019 Nov 20;10:2726. doi: 10.3389/fimmu.2019.02726. eCollection 2019. Front Immunol. 2019. PMID: 31824506 Free PMC article. Review.

3

A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment.

Kenig A, Ilan Y. Kenig A, et al. Among authors: ilan y. Front Physiol. 2019 Dec 19;10:1542. doi: 10.3389/fphys.2019.01542. eCollection 2019. Front Physiol. 2019. PMID: 31920730 Free PMC article. Review.

4

Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents.

Gelman R, Bayatra A, Kessler A, Schwartz A, Ilan Y. Gelman R, et al. Among authors: ilan y. Emerg Microbes Infect. 2020 Dec;9(1):1397-1406. doi: 10.1080/22221751.2020.1776161. Emerg Microbes Infect. 2020. PMID: 32490731 Free PMC article. Review.

5

Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy.

Forkosh E, Kenig A, Ilan Y. Forkosh E, et al. Among authors: ilan y. Pharmacol Res Perspect. 2020 Aug;8(4):e00616. doi: 10.1002/prp2.616. Pharmacol Res Perspect. 2020. PMID: 32608157 Free PMC article. Review.

6

Adropin as a potential mediator of the metabolic system-autonomic nervous system-chronobiology axis: Implementing a personalized signature-based platform for chronotherapy.

Kolben Y, Weksler-Zangen S, Ilan Y. Kolben Y, et al. Among authors: ilan y. Obes Rev. 2021 Feb;22(2):e13108. doi: 10.1111/obr.13108. Epub 2020 Jul 27. Obes Rev. 2021. PMID: 32720402 Review.

7

Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance.

Ilan Y, Spigelman Z. Ilan Y, et al. Cancer Treat Res Commun. 2020;25:100240. doi: 10.1016/j.ctarc.2020.100240. Epub 2020 Nov 19. Cancer Treat Res Commun. 2020. PMID: 33246316 Free article. Review.

8

Establishment of an Individualized Chronotherapy, Autonomic Nervous System, and Variability-Based Dynamic Platform for Overcoming the Loss of Response to Analgesics.

Azmanov H, Ross EL, Ilan Y. Azmanov H, et al. Among authors: ilan y. Pain Physician. 2021 May;24(3):243-252. Pain Physician. 2021. PMID: 33988944 Free article. Review.

9

Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes.

Ilan Y. Ilan Y. Front Digit Health. 2020 Dec 3;2:569178. doi: 10.3389/fdgth.2020.569178. eCollection 2020. Front Digit Health. 2020. PMID: 34713042 Free PMC article.

10

Microtubules as a potential platform for energy transfer in biological systems: a target for implementing individualized, dynamic variability patterns to improve organ function.

Ilan Y. Ilan Y. Mol Cell Biochem. 2023 Feb;478(2):375-392. doi: 10.1007/s11010-022-04513-1. Epub 2022 Jul 13. Mol Cell Biochem. 2023. PMID: 35829870 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters